Randall E. Pollard - 01 Sep 2025 Form 4 Insider Report for HARROW, INC. (HROW)

Reporting relationship: CHIEF ACCOUNTING OFFICER
Issuer ticker: HROW
Reported as of: 01 Sep 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Sep 2025, 21:07:57 UTC
Prior SEC filing: 07 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Andrew R. Boll as Attorney in Fact for Randall Pollard

Key filing fact

Randall E. Pollard filed Form 4 for HARROW, INC. (HROW) on 09 Sep 2025.

Key facts

This page summarizes Randall E. Pollard's Form 4 filing for HARROW, INC. (HROW).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Sep 2025, 21:07.

Change

Previous filing in this sequence was filed on 07 Mar 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001650213 Primary reporting owner

Pollard Randall E.

Relationship: CHIEF ACCOUNTING OFFICER
Address: C/O HARROW, INC., 1A BURTON HILLS BLVD., SUITE 200, NASHVILLE
Signature: /s/ Andrew R. Boll as Attorney in Fact for Randall Pollard
Signature date: 09 Sep 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HROW transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +30,000
Change %
Price: $0.000000
Shares after: 30,000
Date: 01 Sep 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,000
Exercise price: $39.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the option shall vest according to the following schedule: 25% of the shares shall vest at the one-year anniversary of the date of grant, and the remaining shares shall vest over the next three years in 12 equal quarterly installments until fully vested and exercisable on September 1, 2029.